Carbidopa

Descrição detalhada : Carbidopa is a peripheral decarboxylase inhibitor which is often formulated with levodopa for the management of the symptoms of Parkinson?s disease. Its mode of action involves the reduction of systemic production of dopamine and minimization of undesirable effects such as nausea.Pharmaceutical secondary standard for application in quality control. Provides pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.
Sinónimos : (S)-3-(3,4-Dihydroxyphenyl)-2-hydrazino-2-methylpropionic acid monohydrate
Fórmula molecula r: C10H14N2O4 · H2O
Armazenamento : 2-30C
Embalagem : 1X1G